Cargando…

Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid

Background: Voriconazole is an antifungal drug used as one of the first-line treatments for invasive aspergillosis. This drug is extensively metabolized, predominantly via cytochrome P450 enzymes. An interaction between flucloxacillin and voriconazole, leading to subtherapeutic voriconazole concentr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Daele, Ruth, Wauters, Joost, De Cock, Pieter, Buyle, Franky, Leys, John, Van Brantegem, Pieter, Gijsen, Matthias, Annaert, Pieter, Debaveye, Yves, Lagrou, Katrien, Peetermans, Willy E., Brüggemann, Roger J., Spriet, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469006/ https://www.ncbi.nlm.nih.gov/pubmed/34572694 http://dx.doi.org/10.3390/antibiotics10091112

Ejemplares similares

Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study
por: Gijsen, Matthias, et al.
Publicado: (2021)

Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function
por: Gijsen, Matthias, et al.
Publicado: (2022)

Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients
por: Van Daele, Ruth, et al.
Publicado: (2021)

Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis
por: Gijsen, Matthias, et al.
Publicado: (2021)

Meropenem Stability in Human Plasma at −20 °C: Detailed Assessment of Degradation
por: Gijsen, Matthias, et al.
Publicado: (2021)

Isavuconazole in the Treatment of Aspergillus fumigatus Fracture-Related Infection: Case Report and Literature Review
por: Mertens, Beatrijs, et al.
Publicado: (2022)

Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults
por: Gastmans, Heleen, et al.
Publicado: (2022)

Reproducibility of fluid status measured by bioelectrical impedance analysis in healthy volunteers: a key requirement to monitor fluid status in the intensive care unit
por: Gijsen, Matthias, et al.
Publicado: (2021)

Drug-induced cholestasis assay in primary hepatocytes
por: Van Brantegem, Pieter, et al.
Publicado: (2020)

Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review
por: Mertens, Beatrijs, et al.
Publicado: (2023)

External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 Patients
por: Huang, Chao-Yuan, et al.
Publicado: (2023)

Acetaminophen Use Concomitant with Long-Lasting Flucloxacillin Therapy: A Dangerous Combination
por: van den Bersselaar, Luuk René, et al.
Publicado: (2020)

PK/PD of single-dose amikacin in emergency department patients with severe sepsis/shock: should we apply the ICU-based higher loading dose?
por: Winter, S De, et al.
Publicado: (2015)

A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation
por: Van Daele, Ruth, et al.
Publicado: (2021)

In-hospital antibiotic use for severe chronic obstructive pulmonary disease exacerbations: a retrospective observational study
por: Vanoverschelde, Anna, et al.
Publicado: (2023)

High unbound flucloxacillin fraction in critically ill patients
por: Wallenburg, Eveline, et al.
Publicado: (2021)

The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluation
por: Mertens, Beatrijs, et al.
Publicado: (2022)

Flucloxacillin/isavuconazole/voriconazole interaction: Decrease in drug concentration following drug-drug interaction and lack of efficacy: 2 case reports
Publicado: (2022)

Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury
por: Ali, Serat-E, et al.
Publicado: (2023)

Cholestasis Differentially Affects Liver Connexins
por: Cooreman, Axelle, et al.
Publicado: (2020)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Feys, Simon, et al.
Publicado: (2021)

Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?
por: Kantasiripitak, Wannee, et al.
Publicado: (2020)

Broad-spectrum azoles and flucloxacillin: a dangerous match
por: Vangheluwe, Tine, et al.
Publicado: (2021)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

Flucloxacillin and paracetamol induced pyroglutamic acidosis
por: Zand Irani, Anis, et al.
Publicado: (2021)

Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study
por: Berbee, J. K., et al.
Publicado: (2017)

Rapidly Fatal Acanthamoeba Encephalitis and Treatment of Cryoglobulinemia
por: Meersseman, Wouter, et al.
Publicado: (2007)

Can augmented renal clearance be detected using estimators of glomerular filtration rate?
por: Gijsen, Matthias, et al.
Publicado: (2020)

Clinical Efficacy of Temocillin Standard Dosing in Patients Treated with Outpatient Antimicrobial Therapy
por: Van den Broucke, Evelyne, et al.
Publicado: (2022)

Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations
por: Jager, Nynke G L, et al.
Publicado: (2020)

Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, Belgium
por: Desmet, Stefanie, et al.
Publicado: (2022)

Oral Flucloxacillin for Staphylococcal Osteomyelitis: Obsolete or Underused?
por: Tevell, Staffan, et al.
Publicado: (2020)

Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report
por: Verfaillie, Saartje, et al.
Publicado: (2022)

Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia
por: van der Heijden, Charlotte D.C.C., et al.
Publicado: (2019)

Oral flucloxacillin and phenoxymethylpenicillin versus flucloxacillin alone for the emergency department outpatient treatment of cellulitis: study protocol for a randomised controlled trial
por: Quirke, Michael, et al.
Publicado: (2013)

A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue
por: Vanderbeke, Lore, et al.
Publicado: (2023)

Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies
por: Jansen, Anouk M. E., et al.
Publicado: (2023)

Bile Nephropathy in Flucloxacillin-Induced Cholestatic Liver Dysfunction
por: Alnasrallah, Basil, et al.
Publicado: (2016)

2533. Cerebrospinal Fluid Penetration of Cefazolin and Flucloxacillin in Children
por: Boast, Alison, et al.
Publicado: (2023)

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial
por: Vanderbeke, Lore, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n8bqukvng2g0hcmfp9e07g4u0v